Arcadia Biosciences, Inc. (RKDA) Form 8-K — Sep 4, 2026
Arcadia Biosciences received a letter from Nasdaq's Listing Qualifications Department on August 31, 2026, notifying the company that its stockholders' equity of $633,000 as of June 30, 2026 is below the $2,500,000 minimum required for continued listing on the Nasdaq Capital Market under Listing Rule 5550(b)(1). The letter also noted the company fails the alternative standards of market value of listed securities and net income from continuing operations. The letter has no immediate impact on trading, and Arcadia has 45 calendar days, until October 15, 2026, to submit a plan to regain compliance.
Key figures
- Compliance Plan Deadline
- October 15, 2026
- Max Nasdaq Extension Days
- 180
- Stockholders Equity Jun30 2026
- 633000
- Nasdaq Minimum Stockholders Equity
- 2500000
Price after filing
Close on the filing date to close N calendar days later (from $0.47). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.